Chargement…
Manufacturer and distributor of pharmaceutical products, herbal remedies, and dietary supplements based in New Delhi, India since 2015.
IndeFondée en 2015Fabricant · SantéEU GMPPIC/S GMPWHO GMP
clinical study
A clinical study evaluating the efficacy of the phytocomplex Anantavati in treating anxiety and depressive disorders in military personnel exposed to combat stress. The study reports a 40% reduction in depressive symptoms and improvements in sleep, mood, and somatic manifestations.
clinical study
A clinical study evaluating the efficacy, tolerability, and safety of the phytocomposition Memostim in 30 patients with stage II dyscirculatory encephalopathy caused by metabolic syndrome over a 3-month period, demonstrating improvements in neurocognitive function and neuroplasticity.
clinical study
A clinical study evaluating the efficacy and safety of the phytocomplex Memostim (Bacopa Monnieri and Ginkgo Biloba) in 30 patients with stage II dyscirculatory encephalopathy. The study demonstrates significant improvements in cognitive functions, psycho-emotional state, and quality of life, correlated with increased levels of neuronal growth factor (NGF).
clinical study
A comparative, multicenter, open-label study evaluating the efficacy and safety of the Ayurvedic preparation Hepaklin versus Silymarin in 60 patients with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). The study assessed lipid/carbohydrate metabolism, liver function, and gallbladder contractility over 12 weeks.
clinical study
A clinical study evaluating the efficacy of the herbal remedy Glibofit in regulating carbohydrate and lipid metabolism in patients with pre-diabetes and type 2 diabetes mellitus. The study demonstrates that Glibofit, when used in combination with metformin, significantly reduces fasting glucose, glycosylated hemoglobin, and total cholesterol levels.
clinical study
A clinical study evaluating the efficacy of Aziclar (clarithromycin) in treating follicular tonsillitis in adults. The study compared a main group treated with Aziclar against a control group, demonstrating that Aziclar provides more intensive symptom regression, faster normalization of pharyngoscopic patterns, and effective temperature reduction with good tolerability.
clinical study
A clinical study evaluating the efficacy of Aziclar (clarithromycin) in treating urogenital chlamydial infections in 28 patients, demonstrating a 92.2% clinical recovery rate.
clinical study
A scientific conference paper discussing the efficacy and clinical utility of Ananta Ltd's pharmaceutical products, specifically Aziclar (clarithromycin), in treating Helicobacter pylori-associated gastroduodenal diseases. The paper highlights the affordability and therapeutic equivalence of these products compared to other market options.
clinical study
A clinical study evaluating the effectiveness and tolerability of Aziclar (clarithromycin) in 57 patients with urogenital chlamydia and mycoplasma infections, demonstrating high therapeutic efficacy and safety.